• Finerenone and Heart Failure: A New Hope for Patients with Preserved Ejection Fraction

  • Dec 29 2024
  • Length: 17 mins
  • Podcast

Finerenone and Heart Failure: A New Hope for Patients with Preserved Ejection Fraction

Listen for free

View show details

  • Summary

  • In this episode of the "Heartbeat Podcast," we delve into groundbreaking research published in the New England Journal of Medicine on the efficacy of Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, for patients with heart failure and mildly reduced or preserved ejection fraction. Discover how this therapy reduces the risk of worsening heart failure events and cardiovascular mortality, and explore its implications for clinical practice.

    Join us for an in-depth discussion tailored for healthcare professionals and cardiologists seeking the latest advancements in cardiac care.

    #HeartbeatPodcast #HeartFailure #Cardiology #Finerenone #MedicalResearch #CardiacCare #PodcastForDoctors #MedicalPodcast

    • Amazon Music: Listen on Amazon Music
    • Apple Podcasts: Listen on Apple Podcasts
    • Spotify: Listen on Spotify
    • YouTube: Watch on YouTube
    Show More Show Less
Show More Show Less

What listeners say about Finerenone and Heart Failure: A New Hope for Patients with Preserved Ejection Fraction

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.